With periods, pregnancies and pap smears in the rearview mirror, menopausal women may stop tending to health below their waist. A Penn State Health urogynecologist offers women advice as they age.
Researchers from Flinders University and the Robinson Research Institute at the University of Adelaide have identified distinctive biological markers that could improve the routine blood tests pregnant women already undergo and detect risks for pregnancy complications earlier than currently possible.
Hot flashes, one of the most common symptoms of the menopause transition, not only interfere with a woman’s quality of life, but are also associated with an array of health problems.
A newly published study found that women who contract COVID-19 during pregnancy are at significantly higher risk of developing pre-eclampsia, the leading cause of maternal and infant death worldwide.
Women who receive COVID-19 mRNA vaccines during pregnancy pass high levels of antibodies to their babies, a new NYU Langone study finds.
A common antibiotic has been found to reduce low birth weight and premature births, if taken during pregnancy, in countries where malaria is endemic, according to a research review.
The most common hormone disorder affecting women of reproductive age—polycystic ovary syndrome (PCOS)—cost an estimated $8 billion to diagnose and treat nationwide in 2020, according to a new economic analysis published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
A sex education program in Arizona significantly impacted key factors associated with pregnancy prevention among Native American teens.
Some women say their periods change after getting a covid-19 vaccination.
A new 4,600-square-foot, state-of-the-art maternal fetal clinic space located at Monroe Carell Jr. Children’s Hospital at Vanderbilt opened Sept. 13 to allow these specialists to further enhance and grow innovative programming that helps families seek optimal outcomes for their unborn babies.
Women with higher levels of PFAS in their system may be 20% more likely to stop breastfeeding early, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.
Throughout history, pandemics have been a key driver of human population change, thanks to mortality and declining fertility rates. And, according to a new study co-authored by a Cornell professor, COVID-19 is no exception.
Topics include: optimism, social media temptations, stress and cognitive-effort avoidance, biased to see what we want to see, mental health during COVID-19 surge, and maternal depression.
Some medical procedures can put health care workers at higher risk for contracting COVID-19 and other respiratory diseases. With these high-risk procedures, it’s important that health care providers have access to personal protective equipment (PPE), including N95 masks. However, not all procedures that may seem high risk have that designation.
UC San Diego School of Medicine receives $6.1M to launch a new research center studying the effects of maternal antibiotic use on breast milk and infant health. The center is funded by National Institutes of Health, as part of their new Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub.
Adenomyosis – an abnormal tissue growth into the muscular wall of the uterus that causes painful cramps and heavy or prolonged menstrual bleeding – is more common than generally appreciated, a review of the literature by gynecologists at UT Southwestern Medical Center revealed.
About 300,000 to 400,000 fetuses per year from mothers with diabetes develop neural tube defects—when the tissue that eventually forms the brain and spinal cord fails to form properly—which can lead to miscarriage or profound disability.
A new study by UT Southwestern scientists indicates that an enzyme called protein phosphatase 2 (PP2A) appears to be a major driver of preeclampsia, a dangerous pregnancy complication characterized by the development of high blood pressure and excess protein in the urine. The finding, published in Circulation Research, could lead to new treatments for preeclampsia other than premature delivery, which is often the only option.
Researchers found that breastfeeding mothers who received either the Pfizer-BioNTech or Moderna vaccination reported the same local or systemic symptoms as what has been previously reported in non-breastfeeding women, with no serious side effects in the breastfed infants.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
